A Van Der Maas - JoVE Visualize

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Expert Opinion on Drug Metabolism & Toxicology|April 21, 2017

Prediction of successful dose reduction or discontinuation of adalimumab, etanercept, or infliximab in rheumatoid arthritis patients using serum drug levels and antidrug antibody measurementCam Bouman, N van Herwaarden, Fhj van den Hoogen, et al.

Clinical and Experimental Rheumatology|April 30, 2014

Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activityN van Herwaarden, S Herfkens-Hol, A van der Maas, et al.

Rheumatology (Oxford, England)|April 19, 2002

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritisP Barrera, A van der Maas, A E van Ede, et al.

Vaccine|July 17, 2007

Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The NetherlandsHein J Boot, Iris Wallenburg, Hester E de Melker, et al.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 1, 2014

Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination seriesN A van der Maas, L Mollema, G A Berbers, et al.

Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Expert Opinion on Drug Metabolism & Toxicology|April 21, 2017

Prediction of successful dose reduction or discontinuation of adalimumab, etanercept, or infliximab in rheumatoid arthritis patients using serum drug levels and antidrug antibody measurementCam Bouman, N van Herwaarden, Fhj van den Hoogen, et al.

Clinical and Experimental Rheumatology|April 30, 2014

Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activityN van Herwaarden, S Herfkens-Hol, A van der Maas, et al.

Rheumatology (Oxford, England)|April 19, 2002

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritisP Barrera, A van der Maas, A E van Ede, et al.

Vaccine|July 17, 2007

Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The NetherlandsHein J Boot, Iris Wallenburg, Hester E de Melker, et al.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 1, 2014

Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination seriesN A van der Maas, L Mollema, G A Berbers, et al.

Pageof 2